Accordingly, the down-regulation of Cldn-1 has been associated with impaired skin barrier function, enhanced skin permeability, and skin pathologies, such as psoriasis and atopic dermatitis [50,51,52,53,54]. Here, CLDN1 is linked to atopic eczema.